Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

John Burbank, Passport Capital Add to Position in

John Burbank‘s Passport Capital has revealed an increase in their investment in Inc (NYSE:WUBA). In a new filing with the Securities and Exchange Commission, Passport Capital has reported holding of 3.2 million Class A shares, up from 2.8 million shares previously owned. Burbank’s current position represents 11.8% of’s common stock.


Another fund interested in this stock is Robert Pitts‘ Steadfast Capital. Pitts recently acquired a little over 1.8 million shares, or 7.6% of the common stock, held through 904,377 ADR shares., a Chinese provider of online advertising services, went public on October 31st. In the Initial Public Offering (IPO), the company sold 11 million American Depositary Shares (ADS) at $17 a piece. An over-allotment option for an extra 1.65 million ADS has been awarded to the underwriters, with each ADS being equal to two Class A shares. The price took off, rising to $27 apiece during the first day of trading, with shares currently changing hands at approximately $34.6. On November 12, announced that the underwriters of its IPO had exercised in full their options to buy 1.65 million shares at the initial price of $17. As a result, the company’s receipts following the IPO rose to $215 million.

The Chinese giant managed to constantly increase its revenues in the interval 2010 – 2012 from $10.7 million to approximately $87 million. posted revenues of $58.8 million and a profit of $285,000 for the first 6 months of 2013. This was the first time the company reported a positive profit. has $71 million worth of assets under control and debts of approximately $82 million.

Disclosure: none

Recommended reading:

Jana Partners’ Third Quarter Portfolio: Closer to the Chemicals and Pharmaceutical Industries

Lansdowne Partners Reduce Position in LSE-listed Central Asia Metals

Government Announcements Place Fannie Mae and Freddie Mac Between Funds’ Eyebrows

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!